Psychiatric Aspects of Parkinson's Disease, Dementia, Depression, and Rarely Psychosis
BMJ 299:3-4, Baldwin,R.C.&Byrne,E.J., 1989
Effect of Age at Onset on Progression and Mortality in Parkinson's Disease
Neurol 39:1187-1190, Diamond,S.G.,et al, 1989
Diffuse Lewy Body Disease:Clinical Features in 15 Cases
JNNP 52:709-717, Byrne,E.J., 1989
The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989
Trochanteric Sciatic Neuropathy
Neurol 39:1539-1541, Crisci,C.,et al, 1989
Extrapyramidal Features in Central Lyme Borreliosis
Eur Neurol 29:150-155, Kohlhepp,W.,et al, 1989
The Rational Management of Idiopathic Intracranial Hypertension
Arch Neurol 46:1049-1051, Corbett,J.J.&Thompson,H.S., 1989
Magnetic Resonance Imaging in Parkinson's Syndromes
Neurol 39:1524-1526, Stern,M.B.,et al, 1989
Magnetic Resonance Imaging in Dementia of Parkinson's Disease
JNNP 52:1221-1227, Huber,S.J.,et al, 1989
Selegiline Use to Prevent Progression of Parkinson's Disease
Arch Neurol 46:1275-1279, Elizan,T.S.,et al, 1989
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group, NEJM 321:1364-13711989., , 1989
DATATOP:A Multicenter Controlled Clinical Trial in Early Parkinson's Disease
Parkinson Study Group, Arch Neurol 46:1052-10601989., , 1989
Selegiline as an Adjunct to Conventional Levodopa Therapy in Parkinson's Disease
Arch Neurol 46:1280-1283, Elizan,T.S.,et al, 1989
Swallowing Abnormalities and Their Response to Treatment in Parkinson's Disease
Neurol 39:1309-1314, Bushman,M.,et al, 1989
Gerstmann-Straussler-Scheinker Disease, I, Extending the Clinical Spectrum
Neurol 39:1446-1452, Farlow,M.R.,et al, 1989
Mild Parkinsonism in Persons Exposed to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)
Neurol 39:1483-1487, Tetrud,J.W.,et al, 1989
Multifocal Fibrosclerosis with Hypertrophic Intracranial Pachymeningitis
Neurol 39:1345-1349, Berger,J.R.,et al, 1989
Cortical Lewy Body Dementia:Clinical Features and Classification
JNNP 52:185-192, Gibb,W.R.G.,et al, 1989
Lithium Carbonate Intoxication, A Case Report and Review of the Literature
Arch Int Med 149:36-46, Simard,M.,et al, 1989
Bulging Fontanelle after Immunization with Diphtheria-Tetanus-Pertussis Vaccine and Diphtheria-Tetanus Vaccine
J Pediatr 114:423-425, Gross,T.P.,et al, 1989
Amitriptyline in the Treatment of Headache in Patients with Parkinson's Disease:Double-Blind Study
Neurol 38:1720-1721, Indaco,A.&Carrieri,P.B., 1988
Meningitis in Familial Mediterranean Fever
Am J Med 85:715-717, Schwabe,A.D., 1988
Parkinsonian Syndrome Caused by a Tumour of the Left Supplementary Motor Area
JNNP 51:730-731, Straube,A.&Sigel,K., 1988
A Comparison of Clinical and Pathological Features of Young-and Old-Onset Parkinson's Disease
Neurol 38:1402-1406, Gibb,W.R.G.&Lees,A.J., 1988
Clinicopath Conf
Pancreatic Insulinoma, Probably Benign, Case Record 23-1988, NEJM 318:1523-153288., , 1988
Neurologic Disease in Biopsy-Proven Giant Cell (Temporal) Arteritis
Neurol 38:352-359, Caselli,R.J.,et al, 1988
Prevalence and Natural History of Progressive Supranuclear Palsy
Neurol 38:1031-1034, Golbe,L.I.,et al, 1988
Cerebral Hypometabolism in Progressive Supranuclear Palsy Studied with Positron Emission Tomography
Ann Neurol 24:399-406, Foster,N.L.,et al, 1988
Transplantation of Fetal Substantia Nigra & Adrenal Medulla to the Caudate Nucleus in Two Pts with Parkinson'sDisease. Editorial
NEJM 319:370-371, , 1988
Adrenal and Nigral Transplants for Parkinson's Disease
BMJ 296:1211-1212, Pearce,J.M.S., 1988
Ethics of Fetal Brain Cell Transplants
BMJ 296:1212-1213, Gillon,R., 1988
Embryos and Parkinson's Disease
Editorial, Lancet 1:10871988., , 1988
Neural & Adrenal Medullary Transplants as a Treatment for Parkinson's & Other Neurodegenerative Disorders
NeuroView 4:May/June, Lieberman,A.,et al, 1988
Neuropsychological Effects of Brain Autograft of Adrenal Medullary Tissue for Treatment of Parkinson's Disease
Neurol 38:1442-1450, Ostrosky-Solis,F.,et al, 1988
Controlled-Release Carbidopa/Levodopa (CR4-Sinemet) in Parkinson's Disease Pts With & Without Motor Fluctuations
Neurol 38:1143-1146, Goetz,C.G.,et al, 1988
Treatment of Chronic Parkinson's Disease with Controlled-Release Carbidopa/Levodopa
Arch Neurol 45:861-864, Hutton,J.T.,et al, 1988
Practical Application of a Low-Protein Diet for Parkinson's Disease
Neurol 38:1026-1031, Riley,D.&Lang,A.E., 1988
Uneven Pattern of Dopamine Loss in the Striatum with Idiopathic Parkinson's Disease, Pathophysiologic & Clinical Implications
NEJM 318:876-880, Kish,S.J., 1988
A Study of Facial Expression in Parkinson's Disease Using a Novel Microcomputer-Based Method
JNNP 51:362-366, Katsikitis,M.&Pilowsky,I., 1988
Does Levodopa Aggravate Parkinson's Disease
Neurol 38:1410-1416, Blin,J.,et al, 1988
Duodenal and Gastric Delivery of Levodopa in Parkinsonism
Ann Neurol 23:589-595, Kurlan,R.,et al, 1988
Long-Term Duodenal Infusion of Levodopa for Motor Fluctuations in Parkinsonism
Ann Neurol 24:87-89, Sage,J.I.,et al, 1988
Hemiparkinsonism with Hemiatrophy
Neurol 38:527-530, Buchman,A.S.,et al, 1988
Familial Parkinsonism, Apathy, Weight Loss & Central Hypoventilation:Successful Long-Term Management
Neurol 38:637-639, Roy,E.P.,et al, 1988
Parkinson's Disease in a Nationwide Twin Cohort
Neurol 38:1217-1219, Marttila,R.J.,et al, 1988
Comparison of the Prevalence of Parkinson's Disease in Black Populations in the Rural US & Nigeria
Neurol 38:645-646, Schoenberg,B.S.,et al, 1988
Olfactory Dysfunction in Parkinsonism:A General Deficit Unrelated to Neurologic Signs, Disease Stage, or Duration
Neurol 38:1237-1244, Doty,R.L.,et al, 1988
Essential Tremor Cured by Infarction Adjacent to the Thalamus
JNNP 51:591-592, Duncan,R.,et al, 1988
Relief of Orthostatic Tremor by Primidone
Neurol 38:1332, vanDerZwan,A.,et al, 1988
Neuroleptic-Induced Parkinson's Syndrome:Clinical Features and Results of Treatment with Levodopa
JNNP 51:850-854, Hardie,R.J.&Lees,A.J., 1988